171 related articles for article (PubMed ID: 20584905)
1. Isoform-specific prolongation of Kv7 (KCNQ) potassium channel opening mediated by new molecular determinants for drug-channel interactions.
Gao Z; Zhang T; Wu M; Xiong Q; Sun H; Zhang Y; Zu L; Wang W; Li M
J Biol Chem; 2010 Sep; 285(36):28322-32. PubMed ID: 20584905
[TBL] [Abstract][Full Text] [Related]
2. Sequence determinants of subtype-specific actions of KCNQ channel openers.
Wang AW; Yang R; Kurata HT
J Physiol; 2017 Feb; 595(3):663-676. PubMed ID: 27506413
[TBL] [Abstract][Full Text] [Related]
3. Structural determinants of M-type KCNQ (Kv7) K+ channel assembly.
Schwake M; Athanasiadu D; Beimgraben C; Blanz J; Beck C; Jentsch TJ; Saftig P; Friedrich T
J Neurosci; 2006 Apr; 26(14):3757-66. PubMed ID: 16597729
[TBL] [Abstract][Full Text] [Related]
4. The KCNQ2/3 selective channel opener ICA-27243 binds to a novel voltage-sensor domain site.
Padilla K; Wickenden AD; Gerlach AC; McCormack K
Neurosci Lett; 2009 Nov; 465(2):138-42. PubMed ID: 19733209
[TBL] [Abstract][Full Text] [Related]
5. KCNQ2/3 openers show differential selectivity and site of action across multiple KCNQ channels.
Zhang D; Thimmapaya R; Zhang XF; Anderson DJ; Baranowski JL; Scanio M; Perez-Medrano A; Peddi S; Wang Z; Patel JR; DeGoey DA; Gopalakrishnan M; Honore P; Yao BB; Surowy CS
J Neurosci Methods; 2011 Aug; 200(1):54-62. PubMed ID: 21723881
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial augmentation of voltage-gated KCNQ potassium channels by chemical openers.
Xiong Q; Sun H; Zhang Y; Nan F; Li M
Proc Natl Acad Sci U S A; 2008 Feb; 105(8):3128-33. PubMed ID: 18272489
[TBL] [Abstract][Full Text] [Related]
7. Zinc pyrithione-mediated activation of voltage-gated KCNQ potassium channels rescues epileptogenic mutants.
Xiong Q; Sun H; Li M
Nat Chem Biol; 2007 May; 3(5):287-96. PubMed ID: 17435769
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological activity of pyrazolo[1,5-a]pyrimidin-7(4H)-ones as novel Kv7/KCNQ potassium channel activators.
Qi J; Zhang F; Mi Y; Fu Y; Xu W; Zhang D; Wu Y; Du X; Jia Q; Wang K; Zhang H
Eur J Med Chem; 2011 Mar; 46(3):934-43. PubMed ID: 21296466
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiological and pharmacological characterization of a novel and potent neuronal Kv7 channel opener SCR2682 for antiepilepsy.
Zhang F; Liu Y; Tang F; Liang B; Chen H; Zhang H; Wang K
FASEB J; 2019 Aug; 33(8):9154-9166. PubMed ID: 31063701
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Evaluation of Potent KCNQ2/3-Specific Channel Activators.
Kumar M; Reed N; Liu R; Aizenman E; Wipf P; Tzounopoulos T
Mol Pharmacol; 2016 Jun; 89(6):667-77. PubMed ID: 27005699
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Kv7 (KCNQ) K+ channel open probability by phosphatidylinositol 4,5-bisphosphate.
Li Y; Gamper N; Hilgemann DW; Shapiro MS
J Neurosci; 2005 Oct; 25(43):9825-35. PubMed ID: 16251430
[TBL] [Abstract][Full Text] [Related]
12. The acrylamide (S)-2 as a positive and negative modulator of Kv7 channels expressed in Xenopus laevis oocytes.
Blom SM; Schmitt N; Jensen HS
PLoS One; 2009 Dec; 4(12):e8251. PubMed ID: 20011514
[TBL] [Abstract][Full Text] [Related]
13. The expression and function of KCNQ potassium channels in human chorionic plate arteries from women with normal pregnancies and pre-eclampsia.
Wei X; Zhang Y; Yin B; Wen J; Cheng J; Fu X
PLoS One; 2018; 13(3):e0192122. PubMed ID: 29579054
[TBL] [Abstract][Full Text] [Related]
14. Development of an automated screen for Kv7.2 potassium channels and discovery of a new agonist chemotype.
Hernandez CC; Tarfa RA; Miguel I Limcaoco J; Liu R; Mondal P; Hill C; Keith Duncan R; Tzounopoulos T; Stephenson CRJ; O'Meara MJ; Wipf P
Bioorg Med Chem Lett; 2022 Sep; 71():128841. PubMed ID: 35671848
[TBL] [Abstract][Full Text] [Related]
15. The Sensorless Pore Module of Voltage-gated K+ Channel Family 7 Embodies the Target Site for the Anticonvulsant Retigabine.
Syeda R; Santos JS; Montal M
J Biol Chem; 2016 Feb; 291(6):2931-7. PubMed ID: 26627826
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of Calmodulin Regulation of Different Isoforms of Kv7.4 K+ Channels.
Sihn CR; Kim HJ; Woltz RL; Yarov-Yarovoy V; Yang PC; Xu J; Clancy CE; Zhang XD; Chiamvimonvat N; Yamoah EN
J Biol Chem; 2016 Jan; 291(5):2499-509. PubMed ID: 26515070
[TBL] [Abstract][Full Text] [Related]
17. Heteromeric Assembly of Truncated Neuronal Kv7 Channels: Implications for Neurologic Disease and Pharmacotherapy.
Li J; Maghera J; Lamothe SM; Marco EJ; Kurata HT
Mol Pharmacol; 2020 Sep; 98(3):192-202. PubMed ID: 32580997
[TBL] [Abstract][Full Text] [Related]
18. SMIT1 Modifies KCNQ Channel Function and Pharmacology by Physical Interaction with the Pore.
Manville RW; Neverisky DL; Abbott GW
Biophys J; 2017 Aug; 113(3):613-626. PubMed ID: 28793216
[TBL] [Abstract][Full Text] [Related]
19. Functional and behavioral signatures of Kv7 activator drug subtypes.
Kanyo R; Wang CK; Locskai LF; Li J; Allison WT; Kurata HT
Epilepsia; 2020 Aug; 61(8):1678-1690. PubMed ID: 32652600
[TBL] [Abstract][Full Text] [Related]
20. A Calmodulin C-Lobe Ca
Chang A; Abderemane-Ali F; Hura GL; Rossen ND; Gate RE; Minor DL
Neuron; 2018 Feb; 97(4):836-852.e6. PubMed ID: 29429937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
